MARY ANN GRAY
CIK 1261974 · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.56M
Companies
15
Total Filings
94
Lifetime Open-Market Net
-$829.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KROS | Director | 12,392 | $10.15 | $125.8K | $0 | 7 | 2026-06-05 |
| RAPT Therapeutics, Inc. (RAPT) Delisted | Director | 4,956 | $58.01 | $287.5K | $0 | 14 | 2026-02-02 |
| CMPX | Director | — | $2.03 | — | $0 | 5 | 2026-01-05 |
| BCAB | Director | 77,397 | $3.86 | $298.8K | $0 | 9 | 2025-06-18 |
| PALI | Director | — | $1.71 | — | $0 | 3 | 2023-11-24 |
| SRPT | Director | 12,356 | $15.31 | $189.2K | $0 | 8 | 2022-03-08 |
| PALISADE BIO, INC. (SNCA) Delisted | Director | — | $9.96 | — | $0 | 2 | 2021-04-26 |
| SENOMYX INC (SNMX) Delisted | Director | 0 | — | — | $10.0K | 10 | 2018-11-02 |
| JUNIPER PHARMACEUTICALS INC (JNP) Delisted | Director | 0 | — | — | $0 | 4 | 2018-08-15 |
| SELLAS Life Sciences Group, Inc. (GALE) Delisted | Director | 39,167 | — | — | $0 | 6 | 2017-10-10 |
| ACAD | Director | 139,476 | $21.09 | $2.94M | -$847.8K | 13 | 2016-06-09 |
| DYAX CORP (DYAX) Delisted | Director | 0 | — | — | $0 | 5 | 2016-01-22 |
| TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted | Director | — | — | — | $0 | 2 | 2015-01-30 |
| GTC BIOTHERAPEUTICS INC (GTCB) Delisted | Director | 11,000 | — | — | $8.8K | 3 | 2008-06-25 |
| MABVAX THERAPEUTICS HOLDINGS, INC. (TELK) Delisted | Director | — | — | — | $0 | 2 | 2008-05-22 |
Recent Filings · Page 3 of 10
94 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-08 | KROS | Grant (A) | — | $0 | EDGAR |
| 2023-05-25 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-15 | BCAB | Grant (A) | +5,503 | $0 | EDGAR |
| 2023-04-10 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-02-09 | CMPX | Grant (A) | — | $0 | EDGAR |
| 2022-06-17 | BCAB | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | KROS | Grant (A) | — | $0 | EDGAR |
| 2022-05-26 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-04-28 | CMPX | Grant (A) | — | $0 | EDGAR |
| 2022-04-04 | RAPT Therapeutics, Inc. (RAPT) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.